Literature DB >> 27220668

Aberrations identified by genomic arrays in normal karyotype CMML can be detected in 40% of patients, but do not add prognostic information to molecular mutations.

C Vetro1,2, C Haferlach1, T Haferlach1, M Zenger1, N Nadarajah1, W Kern1, M Meggendorfer1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27220668     DOI： 10.1038/leu.2016.158

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Mutation in TET2 in myeloid cancers.

Authors:  Ayalew Tefferi; Ken-Hong Lim; Ross Levine
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

2.  Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.

Authors:  Manja Meggendorfer; Torsten Haferlach; Tamara Alpermann; Sabine Jeromin; Claudia Haferlach; Wolfgang Kern; Susanne Schnittger
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

3.  SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.

Authors:  M Meggendorfer; U Bacher; T Alpermann; C Haferlach; W Kern; C Gambacorti-Passerini; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

4.  Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Authors:  Esperanza Such; José Cervera; Dolors Costa; Francesc Solé; Teresa Vallespí; Elisa Luño; Rosa Collado; María J Calasanz; Jesús M Hernández-Rivas; Juan C Cigudosa; Benet Nomdedeu; Mar Mallo; Felix Carbonell; Javier Bueno; María T Ardanaz; Fernando Ramos; Mar Tormo; Reyes Sancho-Tello; Consuelo del Cañizo; Valle Gómez; Victor Marco; Blanca Xicoy; Santiago Bonanad; Carmen Pedro; Teresa Bernal; Guillermo F Sanz
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

5.  Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

Authors:  Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; Seiji Kojima; Alan F List; Mikkael A Sekeres; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

6.  Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

Authors:  Lukasz P Gondek; Ramon Tiu; Christine L O'Keefe; Mikkael A Sekeres; Karl S Theil; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-22       Impact factor: 22.113

7.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

Review 8.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

9.  Guidelines for genomic array analysis in acquired haematological neoplastic disorders.

Authors:  Jacqueline Schoumans; Javier Suela; Ros Hastings; Dominique Muehlematter; Katrina Rack; Eva van den Berg; H Berna Beverloo; Marian Stevens-Kroef
Journal:  Genes Chromosomes Cancer       Date:  2016-02-23       Impact factor: 5.006

10.  Prognostic score including gene mutations in chronic myelomonocytic leukemia.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Véronique Gelsi-Boyer; Manja Meggendorfer; Margot Morabito; Céline Berthon; Lionel Adès; Pierre Fenaux; Odile Beyne-Rauzy; Norbert Vey; Thorsten Braun; Torsten Haferlach; François Dreyfus; Nicholas C P Cross; Claude Preudhomme; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Susanne Schnittger; Daniel Birnbaum; Nathalie Droin; Eric Solary
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544
View more
  1 in total

Review 1.  Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms.

Authors:  Laura Palomo; Pamela Acha; Francesc Solé
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.